Merck shares rose 1.27% in premarket trading.

Tiger Newspress2021-12-22

Merck shares rose 1.27% in premarket trading.

Merck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.

In the U.K., Lagevrio is the planned trademark for molnupiravir.

This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.

In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.

Also, Merck  has entered into a procurement agreement with the U.S. to supply ~3.1M courses of molnupiravi rand to deliver 1.6M courses to Japan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • SSVC
    2021-12-23
    SSVC
    Good Appreciate your response and comments Thanks 
    • SSVC
      [Strong][ShakeHands]
    • Alfred1007
      looks stable..one of the top biopharma companies in the world.
  • Success88
    2021-12-23
    Success88
    Good 
  • BoonHuat
    2021-12-22
    BoonHuat
    Nice!
  • TK360
    2021-12-22
    TK360
    Nice 
  • CHOOTC
    2021-12-22
    CHOOTC
    👍 
  • ppp00
    2021-12-22
    ppp00
    Please help to like 
Leave a comment
18